Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Howlett

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.
The Canadian Journal of Cardiology|May 24, 2011
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative careRobert S McKelvie, Gordon W Moe, Anson Cheung, et al.
European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
The Canadian Journal of Cardiology|December 4, 2012
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failureRobert S McKelvie, Gordon W Moe, Justin A Ezekowitz, et al.
The Canadian Journal of Cardiology|February 1, 2014
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization, Gordon W Moe, Justin A Ezekowitz, et al.
Circulation|July 17, 2020
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HFAlice M Jackson, Pooja Dewan, Inder S Anand, et al.
The Canadian Journal of Cardiology|December 24, 2014
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implicationsGordon W Moe, Justin A Ezekowitz, Eileen O'Meara, et al.
The Canadian Journal of Cardiology|November 8, 2017
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart FailureJustin A Ezekowitz, Eileen O'Meara, Michael A McDonald, et al.
CJC Open|May 29, 2020
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey, Sean A Virani, Shelley Zieroth, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.
The Canadian Journal of Cardiology|May 24, 2011
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative careRobert S McKelvie, Gordon W Moe, Anson Cheung, et al.
European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
The Canadian Journal of Cardiology|December 4, 2012
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failureRobert S McKelvie, Gordon W Moe, Justin A Ezekowitz, et al.
The Canadian Journal of Cardiology|February 1, 2014
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization, Gordon W Moe, Justin A Ezekowitz, et al.
Circulation|July 17, 2020
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HFAlice M Jackson, Pooja Dewan, Inder S Anand, et al.
The Canadian Journal of Cardiology|December 24, 2014
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implicationsGordon W Moe, Justin A Ezekowitz, Eileen O'Meara, et al.
The Canadian Journal of Cardiology|November 8, 2017
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart FailureJustin A Ezekowitz, Eileen O'Meara, Michael A McDonald, et al.
CJC Open|May 29, 2020
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey, Sean A Virani, Shelley Zieroth, et al.
Pageof 13